MedTrace Logo

Safety & Efficacy of the Laser Scleral Microporation Procedure

NCT05068479 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 38

Last updated 2023-10-03

No results posted yet for this study

Summary

A new minimally invasive procedure for treating presbyopia is being evaluated to determine if there is improvement in near and intermediate vision after treatment

Conditions

Interventions

DEVICE

Bilateral Laser Scleral Microporation procedure

Partial depth scleral microporations with an Er:YAG laser in a predetermined pattern.

Sponsors & Collaborators

  • ACE Vision Group, Inc.

    lead INDUSTRY

Principal Investigators

  • Mitchell Jackson, MD · Ace Vision Group

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
48 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-29
Primary Completion
2023-03-29
Completion
2023-03-29

Countries

  • Panama

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05068479 on ClinicalTrials.gov